These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 9365601

  • 21. RS-61443 for treatment-resistant human liver rejection.
    Klintmalm GB, Ascher NL, Busuttil RW, Deierhoi M, Gonwa TA, Kauffman R, McDiarmid S, Poplawski S, Sollinger H, Roberts J.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):697. PubMed ID: 8438442
    [No Abstract] [Full Text] [Related]

  • 22. Tacrolimus and mycophenolate mofetil in clinical liver transplantation: experience with a steroid-sparing concept.
    Ringe B, Braun F, Lorf T, Canelo R, Schütz E, Sattler B, Ramadori G.
    Transplant Proc; 1998 Jun; 30(4):1415-6. PubMed ID: 9636573
    [No Abstract] [Full Text] [Related]

  • 23. Mycophenolate mofetil versus azathioprine in simultaneous pancreas-kidney transplant recipients on cyclosporine.
    Fabrega AJ, Corwin CL, Hunsicker L.
    Transplant Proc; 1998 Jun; 30(4):1562-3. PubMed ID: 9636634
    [No Abstract] [Full Text] [Related]

  • 24. Mycophenolate mofetil with lower cyclosporine dose in high-risk renal transplant recipients.
    Esmeraldo RM, Donadi MO, Oliveira ML, Ponte CN, Pinheiro PM.
    Transplant Proc; 1999 Nov; 31(7):3007-8. PubMed ID: 10578367
    [No Abstract] [Full Text] [Related]

  • 25. Prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil: complete report on 350 primary adult liver transplantations.
    Jain A, Kashyap R, Kramer D, Dodson F, Hamad I, Starzl TE, Fung JJ.
    Transplant Proc; 2001 Nov; 33(1-2):1342-4. PubMed ID: 11267319
    [No Abstract] [Full Text] [Related]

  • 26. Relation of mycophenolic acid trough levels and adverse events in kidney allograft recipients.
    Smak Gregoor PJ, Hesse CJ, van Gelder T, van der Mast BJ, IJzermans JN, van Besouw NM, Weimar W.
    Transplant Proc; 1998 Jun; 30(4):1192-3. PubMed ID: 9636482
    [No Abstract] [Full Text] [Related]

  • 27. Mycophenolate mofetil for treatment of chronic rejection in liver allograft under tacrolimus.
    Daly I, Jain A, Reyes J, Fung J.
    Transplant Proc; 2002 Aug; 34(5):1503. PubMed ID: 12176458
    [No Abstract] [Full Text] [Related]

  • 28. Mycophenolate mofetil rescue therapy in liver transplant recipients: an extended follow-up.
    Gavlik A, Demirbas A, Tsaroucha A, Webb MG, Nery JR, Khan MF, Karatzas T, Khan RT, Zucker K, Viciana AL, Miller JA, Tzakis AG.
    Transplant Proc; 1997 Nov; 29(7):2971-2. PubMed ID: 9365633
    [No Abstract] [Full Text] [Related]

  • 29. Risk and benefit of antibody induction therapy in combination with tacrolimus immunosuppression after liver transplantation.
    Klupp J, Bechstein WO, Pratschke J, Tullius SG, Gebhard A, Lobeck H, Langrehr JM, Neuhaus R, Neuhaus P.
    Transplant Proc; 1998 Jun; 30(4):1443-4. PubMed ID: 9636585
    [No Abstract] [Full Text] [Related]

  • 30. Evaluation of various immunosuppressive regimes in second renal transplants.
    Toronyi E, Remport A, Járay J, Máthé Z, Borka P, Perner F.
    Transplant Proc; 2001 May; 33(3):2315-6. PubMed ID: 11377543
    [No Abstract] [Full Text] [Related]

  • 31. Combining FK 506 and mycophenolate mofetil for the treatment of acute corticosteroid-resistant rejection following kidney transplantation: a new therapeutic concept.
    Carl S, Dörsam J, Mandelbaum A, Staehler G, Wiesel M.
    Transplant Proc; 1998 Jun; 30(4):1236-7. PubMed ID: 9636502
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Early steroid-resistant rejection following orthotopic liver transplantation: new aspects of treatment with FK 506 instead of OKT3?
    Dé P, Bechstein WO, Blumhardt G, Lange D, Schattenfroh N, Neuhaus P.
    Transplant Proc; 1993 Aug; 25(4):2693-4. PubMed ID: 7689279
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW.
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [Abstract] [Full Text] [Related]

  • 36. MMF-based regimen in maintenance therapy after kidney transplantation.
    Wu MJ, Shu KH, Cheng CH, Chen CH, Lian JD.
    Transplant Proc; 2000 Nov; 32(7):1748-50. PubMed ID: 11119918
    [No Abstract] [Full Text] [Related]

  • 37. Significance of mycophenolate mofetil treatment in patients with HCV reinfection after liver transplantation: impact on clinical course and histologic damage.
    Bahra M, Neumann UP, Harren M, Jacob D, Langrehr JM, Berg T, Neuhaus R, Neuhaus P.
    Transplant Proc; 2002 Nov; 34(7):2934-5. PubMed ID: 12431663
    [No Abstract] [Full Text] [Related]

  • 38. Does initial graft function influence the outcome after liver transplantation?
    Mueller AR, Platz KP, Krause P, Neuhaus R, Lobeck H, Neuhaus P.
    Transplant Proc; 1998 Jun; 30(4):1464-5. PubMed ID: 9636594
    [No Abstract] [Full Text] [Related]

  • 39. Mycophenolate mofetil is superior in combination with tacrolimus compared to cyclosporine for immunosuppressive therapy after liver transplantation.
    Glanemann M, Klupp J, Langrehr JM, Platz KP, Schröer G, Raakow R, Stange B, Settmacher U, Bechstein WO, Neuhaus P.
    Transplant Proc; 2001 Jun; 33(1-2):1069-70. PubMed ID: 11267194
    [No Abstract] [Full Text] [Related]

  • 40. Mycophenolate mofetil-induced ischemic colitis.
    Kim HC, Park SB.
    Transplant Proc; 2000 Nov; 32(7):1896-7. PubMed ID: 11119990
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.